Incidence of Invasive Fungal Disease in Patients Receiving Immunosuppressive Therapy, Intensive Chemotherapy or Reduced Intensity Haematopoietic Stem Cell Transplantation on Posaconazole Prophylaxis
Phase of Trial: Phase IV
Latest Information Update: 21 Feb 2018
At a glance
- Drugs Posaconazole (Primary)
- Indications Mycoses
- Focus Therapeutic Use
- Acronyms KIASII
- 19 Feb 2018 Status changed from active, no longer recruiting to recruiting.
- 15 Feb 2018 Planned End Date changed from 1 Nov 2018 to 30 May 2020.
- 06 Nov 2017 Status changed from recruiting to active, no longer recruiting.